Profil
Ryan V.
Hartwell is the founder of BirchBioMed, Inc. Prior to that, he worked as the Chief Scientific Officer and Chief Science Officer at Mind Cure Health, Inc. He holds a doctorate degree from the University of British Columbia and an undergraduate degree from the University of Ottawa.
Aktive Positionen von Ryan V. Hartwell
Unternehmen | Position | Beginn |
---|---|---|
BirchBioMed, Inc.
BirchBioMed, Inc. Pharmaceuticals: MajorHealth Technology BirchBioMed, Inc. operates as a clinical-stage biomedical company. It focuses on the clinical evaluation, development, and commercialization of anti-scarring drugs, autoimmune therapeutics and novel strategies for transplantation. The company was founded by Mark S. Miller, Ryan V. Hartwell and Susan M. Elliott and is headquartered in King City, Canada. | Gründer | - |
Ehemalige bekannte Positionen von Ryan V. Hartwell
Unternehmen | Position | Ende |
---|---|---|
LNG ENERGY GROUP CORP. | Technik-/Wissenschafts-/F&E-Leiter | 04.06.2021 |
LNG ENERGY GROUP CORP. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Ryan V. Hartwell
University of British Columbia | Doctorate Degree |
University of Ottawa | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
BirchBioMed, Inc.
BirchBioMed, Inc. Pharmaceuticals: MajorHealth Technology BirchBioMed, Inc. operates as a clinical-stage biomedical company. It focuses on the clinical evaluation, development, and commercialization of anti-scarring drugs, autoimmune therapeutics and novel strategies for transplantation. The company was founded by Mark S. Miller, Ryan V. Hartwell and Susan M. Elliott and is headquartered in King City, Canada. | Health Technology |
Mind Cure Health, Inc.
Mind Cure Health, Inc. Pharmaceuticals: OtherHealth Technology Mind Cure Health, Inc. operates as a life sciences company to identify and develop products that enhance mental health and wellness. The firm focuses on developing digital therapeutics technology and researching psychedelic compounds to rapidly scale science-backed and evidence-based mental health therapy globally. Its software iSTYRM is designed to provide close to real-time data regarding patient care, procedures and protocols, and other resources for therapists, practitioners and patients with mental health concerns. The company was founded by Philip Tapley on March 6, 2020 and is headquartered in Vancouver, Canada. | Health Technology |